Clearsight Advises Deloitte on the Sale of its Life Sciences Pricing and Contracting Solutions Business to Model N

Clearsight Advisors, Inc. is pleased to announce that it served as exclusive financial advisor to Deloitte & Touche LLP on the sale of its life sciences pricing and contracting solutions business (PaCS) and underlying technology to Model N, Inc. (NYSE: MODN), which closed on December 31, 2020.

The transaction broadens Model N’s portfolio to better serve a larger segment of the market from pre-commercial to the largest life sciences companies in the world. It also brings new life sciences customers, talent and intellectual property that complement Model N’s robust customer base and market-leading offering.

For more information on this transaction, see the full press release on Business Wire.